Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|6|684-691

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.6, 2010-02, pp. : 684-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

By  

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 168-185

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal and Vascular Oxidative Stress in Alzheimer's Disease

By  

Current Neuropharmacology, Vol. 9, Iss. 4, 2011-12 ,pp. : 662-673

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2766-2778

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implications

By Higuchi M.  

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

The Glutamatergic System and Alzheimer’s Disease: Therapeutic Implications

By Butterfield D.A.   Pocernich C.B.  

CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. : 641-652

Adis International

Access to resources Recommend Favorite